TY - JOUR
T1 - Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease
AU - Lu, Hao
AU - Galeano, Maria C.Rondón
AU - Ott, Elisabeth
AU - Kaeslin, Geraldine
AU - Kausalya, P. Jaya
AU - Kramer, Carina
AU - Ortiz-Brüchle, Nadina
AU - Hilger, Nadescha
AU - Metzis, Vicki
AU - Hiersche, Milan
AU - Tay, Shang Yew
AU - Tunningley, Robert
AU - Vij, Shubha
AU - Courtney, Andrew D.
AU - Whittle, Belinda
AU - Wühl, Elke
AU - Vester, Udo
AU - Hartleben, Björn
AU - Neuber, Steffen
AU - Frank, Valeska
AU - Little, Melissa H.
AU - Epting, Daniel
AU - Papathanasiou, Peter
AU - Perkins, Andrew C.
AU - Wright, Graham D.
AU - Hunziker, Walter
AU - Gee, Heon Yung
AU - Otto, Edgar A.
AU - Zerres, Klaus
AU - Hildebrandt, Friedhelm
AU - Roy, Sudipto
AU - Wicking, Carol
AU - Bergmann, Carsten
N1 - Publisher Copyright:
© 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Autosomal recessive polycystic kidney disease (ARPKD), usually considered to be a genetically homogeneous disease caused by mutations in PKHD1, has been associated with ciliary dysfunction. Here, we describe mutations in DZIP1L, which encodes DAZ interacting protein 1-like, in patients with ARPKD. We further validated these findings through loss-of-function studies in mice and zebrafish. DZIP1L localizes to centrioles and to the distal ends of basal bodies, and interacts with septin2, a protein implicated in maintenance of the periciliary diffusion barrier at the ciliary transition zone. In agreement with a defect in the diffusion barrier, we found that the ciliary-membrane translocation of the PKD proteins polycystin-1 and polycystin-2 is compromised in DZIP1L-mutant cells. Together, these data provide what is, to our knowledge, the first conclusive evidence that ARPKD is not a homogeneous disorder and further establish DZIP1L as a second gene involved in ARPKD pathogenesis.
AB - Autosomal recessive polycystic kidney disease (ARPKD), usually considered to be a genetically homogeneous disease caused by mutations in PKHD1, has been associated with ciliary dysfunction. Here, we describe mutations in DZIP1L, which encodes DAZ interacting protein 1-like, in patients with ARPKD. We further validated these findings through loss-of-function studies in mice and zebrafish. DZIP1L localizes to centrioles and to the distal ends of basal bodies, and interacts with septin2, a protein implicated in maintenance of the periciliary diffusion barrier at the ciliary transition zone. In agreement with a defect in the diffusion barrier, we found that the ciliary-membrane translocation of the PKD proteins polycystin-1 and polycystin-2 is compromised in DZIP1L-mutant cells. Together, these data provide what is, to our knowledge, the first conclusive evidence that ARPKD is not a homogeneous disorder and further establish DZIP1L as a second gene involved in ARPKD pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=85021718838&partnerID=8YFLogxK
U2 - 10.1038/ng.3871
DO - 10.1038/ng.3871
M3 - Article
SN - 1061-4036
VL - 49
SP - 1025
EP - 1034
JO - Nature Genetics
JF - Nature Genetics
IS - 7
ER -